期刊文献+

ki-67、细胞周期蛋白依赖性激酶4在胆脂瘤型中耳乳突炎中的表达及意义 被引量:1

The expression and significance of ki-67、CDK4 in the middle ear cholesteatoma epithelium
在线阅读 下载PDF
导出
摘要 目的探讨ki-67、细胞周期蛋白依赖性激酶4(CDK4)在中耳继发胆脂瘤上皮中的表达,研究它们在胆脂瘤型中耳乳突炎中的作用。方法利用免疫组化的方法,检察32例胆脂瘤上皮和11例正常外耳道皮肤中的ki-67、CDK4蛋白的表达情况。结果ki-67在胆脂瘤上皮和外耳道皮肤中均为阳性表达,阳性细胞率分别为33.2%±13.2%、14.5%±4.9%,两组之间的差异具有显著性(P<O.05);CDK4在胆脂瘤上皮和外耳道皮肤中阳性细胞率分别为35.6%±14.6%、13.6%±5.1%,两组之间的差异具有显著性(P=O.001)。结论ki-67和CDK4在胆脂瘤上皮表达增高。 YE Hui-ping1 , CHEN Qian-mei1,Fan Lu1,Jiang Ke-hui2, LIN Shang-ze1Department of Otolaryngology , Affiliated Hospital of Guiyang Medical College, Guiyang 550004Department of Otolaryngology ,Zunyi Hospital 563001Obejective In this study,we aimed to investigate the role of ki-67?CDK4 in the etiology of middle ear cholesteatoma .Methods The expression of ki-67?CDK4 in the cholesteatoma epithelium(n=32) and in the skin of the external ear canal(n=11) were investigated by an immunohistochemical technique.Results ki-67 was expressed dominantly in the stratum basale and stratum spinosum of cholesteatoma epithelium,but only in the stratum basale of external ear canal skin; CDK4 was expressed mainly in the basal and parabasal cell layers of cholesteatoma epithelium and external ear canal skin. The CDK4-positive cell rate is 35.6%±14.6% and 13.6%±5.1%, respectively. The expression of ki-67 and CDK4 showed significantly difference between two groups of specimens .Conclusion The cholesteatoma epithelium have hyperproliferative ability,which may be contributed to by CDK4.
出处 《中华耳科学杂志》 CSCD 2004年第2期126-128,共3页 Chinese Journal of Otology
关键词 KI-67 细胞周期蛋白依赖性激酶4 胆脂瘤型中耳乳突炎 免疫组化 细胞因子 Cholesteatoma Hyperproliferation ki-67 CDK4
  • 相关文献

参考文献13

  • 1[2]Desloge RB ,Finstad CL, Sassoon J, et al. Altered regulation of cell surface peptidases in human cholesteatoma. Otolaryngology Head and Neck Surgery .1997, 116: 58-63.
  • 2[3]Sudhoff H, Bujia J, Fisseler-Eekhoff A, et al. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope. 1995,105: 1227-1231.
  • 3[4]Tanaka Y, Shiwa M, Kojima H, et al. A study on epidermal prolifilation ability in cholesteatomas. Laryngoscope,1998,108: 537-542.
  • 4[6]Tanaka Y, Kojima H, Miyazaki H, et al. Roles of cytokines and cell cycle regulating substances in prolifiration of cholesteatoma epithelium. Laryngoscope. 1999,109:1102-1107.
  • 5[7]Gerdes J, Schwab U, Lemke H, Stein H. Production of mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983, 31: 13-20.
  • 6[8]Mayot D, Bene MC, Perrin C, et al. Restricted expression of Ki-67 in cholesteatoma epithelium. Arch Otolaryngol Head Neck Surg.1993,119:656-658.
  • 7[9]Ergun S, Zheng X, Carlsoo B. Antigen expression of epithelial markers, collagen Ⅳ and Ki67 in middle ear cholesteatoma. An immunohistochemical Study. Acta Otolaryngol. 1994,114:295-302.
  • 8[10]Bujia J, Holly A, Antoli-Candela F, et al. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope. 1996,106:865-868.
  • 9[11]Chae SW, Song JJ, Suh HK, et al. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium. Laryngoscope. 2000;110:1898-1901.
  • 10许昱,金康业,董卫国.Ki67和转化生长因子α在中耳胆脂瘤中的表达[J].中华耳鼻咽喉科杂志,1999,34(5):320-320. 被引量:5

共引文献4

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部